tag patent-litigation 
pharmaphorum
FEBRUARY 26, 2021
Litigation & controversy. Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents. billion) hit the company in 2019. billion the following February.
The Pharma Data
MAY 4, 2021
down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. Patent and Trade Office issued a U.S. Patent Term Extension certificate extending the term of U.S. Chantix in the U.S.,
Expert insights. Personalized for you.
116 
Let's personalize your content